Supplemental Table 1 from Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Table 1 PDF file 56K, Comparisons of time-to-event curves for single or combined antibody therapy against pediatric sarcoma xenografts (listed are adjusted p-values)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361883756